Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Contemporary Options for the Management of Motor Complications in Parkinson’s Disease: Updated Clinical Review
Verónica Cabreira, Patrı́cio Soares-da-Silva, João Massano
Drugs (2019) Vol. 79, Iss. 6, pp. 593-608
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Doença de Parkinson: Revisão Clínica e Atualização
Verónica Cabreira, João Massano
Acta Médica Portuguesa (2019) Vol. 32, Iss. 10, pp. 661-670
Open Access | Times Cited: 154
Improvements in clinical signs of Parkinson’s disease using photobiomodulation: a prospective proof-of-concept study
Ann Liebert, Brian Bicknell, E‐Liisa Laakso, et al.
BMC Neurology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 75
A deep learning approach for parkinson’s disease severity assessment
Tunç Aşuroğlu, Hasan Oğul
Health and Technology (2022) Vol. 12, Iss. 5, pp. 943-953
Open Access | Times Cited: 41
Molecular pathways: the quest for effective MAO-B inhibitors in neurodegenerative therapy
Mega Obukohwo Oyovwi, Onoriode Andrew Udi, Adedeji David Atere, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access | Times Cited: 1
Intrastriatal administration of coenzyme Q10 enhances neuroprotection in a Parkinson’s disease rat model
Hyung Woo Park, Chun Gwon Park, Min Jung Park, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 52
Influence of the COVID-19 Pandemic on Quality of Life of Patients with Parkinson’s Disease
Dengjun Guo, Bing Han, Yu-Qiang Lu, et al.
Parkinson s Disease (2020) Vol. 2020, pp. 1-6
Open Access | Times Cited: 51
New drug approvals for 2019: Synthesis and clinical applications
Shuo Yuan, Bin Yu, Hong‐Min Liu
European Journal of Medicinal Chemistry (2020) Vol. 205, pp. 112667-112667
Closed Access | Times Cited: 49
A Stage-Based Approach to Therapy in Parkinson’s Disease
Claudia Carrarini, Mirella Russo, Fedele Dono, et al.
Biomolecules (2019) Vol. 9, Iss. 8, pp. 388-388
Open Access | Times Cited: 46
Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications
Angelo Antonini, Per Odin, Péter Schmidt, et al.
Parkinsonism & Related Disorders (2021) Vol. 92, pp. 59-66
Open Access | Times Cited: 39
Guidelines for Parkinson’s disease treatment: consensus from the Movement Disorders Scientific Department of the Brazilian Academy of Neurology - motor symptoms
Roberta Arb Saba, Débora Palma Maia, Francisco Cardoso, et al.
Arquivos de Neuro-Psiquiatria (2022) Vol. 80, Iss. 3, pp. 316-329
Open Access | Times Cited: 21
Mitigation of Neuroinflammation and Oxidative Stress in Rotenone-Induced Parkinson Mouse Model through Liposomal Coenzyme-Q10 Intervention: A Comprehensive In-vivo Study
Hajira Umer, Ali Sharif, Humaira Majeed Khan, et al.
Inflammation (2025)
Open Access
Istradefylline to Treat Patients with Parkinson’s Disease Experiencing “Off” Episodes: A Comprehensive Review
Amnon A. Berger, Ariel Winnick, Alexandra Welschmeyer, et al.
Neurology International (2020) Vol. 12, Iss. 3, pp. 109-129
Open Access | Times Cited: 32
Opicapone: A Review in Parkinson’s Disease
Lesley J. Scott
CNS Drugs (2021) Vol. 35, Iss. 1, pp. 121-131
Closed Access | Times Cited: 21
Intrajejunal Infusion of Levodopa/Carbidopa for Advanced Parkinson's Disease: A Systematic Review
Taiji Tsunemi, Genko Oyama, Shinji Saiki, et al.
Movement Disorders (2021) Vol. 36, Iss. 8, pp. 1759-1771
Open Access | Times Cited: 17
Efficacy and safety of non‐ergot dopamine‐receptor agonists as an adjunct to levodopa in advanced Parkinson's disease: A network meta‐analysis
Xiang‐Ting Chen, Qian Zhang, Siyuan Wen, et al.
European Journal of Neurology (2022) Vol. 30, Iss. 3, pp. 762-773
Open Access | Times Cited: 11
Levodopa Inhalation Powder: A Review in Parkinson’s Disease
Julia Paik
Drugs (2020) Vol. 80, Iss. 8, pp. 821-828
Closed Access | Times Cited: 17
Nanoparticles-based delivery system and its potentials in treating central nervous system disorders
Tianyou Liu, Qinglian Xie, Zaiquan Dong, et al.
Nanotechnology (2022) Vol. 33, Iss. 45, pp. 452001-452001
Closed Access | Times Cited: 10
Comparative efficacy and safety of six non-ergot dopamine-receptor agonists in early Parkinson's disease: a systematic review and network meta-analysis
Xiang‐Ting Chen, Qian Zhang, Feifei Chen, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 6
Daidzein exerts neuroprotective activity against MPTP‐induced Parkinson's disease in experimental mice and lipopolysaccharide‐induced BV2 microglial cells
Qiong Wu, Maode Wang, Wei Chen, et al.
Journal of Biochemical and Molecular Toxicology (2021) Vol. 36, Iss. 2
Closed Access | Times Cited: 13
Exceeding the Limits with Nutraceuticals: Looking Towards Parkinson’s Disease and Frailty
Martina Montanari, Nicola Biagio Mercuri, Giuseppina Martella
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 122-122
Open Access | Times Cited: 1
Absorption, metabolism and excretion of opicapone in human healthy volunteers
Ana I. Loureiro, Francisco Rocha, A. Santos, et al.
British Journal of Clinical Pharmacology (2022) Vol. 88, Iss. 10, pp. 4540-4551
Open Access | Times Cited: 7
CASTELO: clustered atom subtypes aided lead optimization—a combined machine learning and molecular modeling method
Leili Zhang, Giacomo Domeniconi, Chih-Chieh Yang, et al.
BMC Bioinformatics (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Difference in rural and urban Medicare prescription pattern for Parkinson’s disease in Hawai‘i
Michiko Kimura Bruno, Gina Watanabe, Fay Gao, et al.
Clinical Parkinsonism & Related Disorders (2022) Vol. 6, pp. 100144-100144
Open Access | Times Cited: 4
Improvements in clinical signs of Parkinson’s disease using photobiomodulation: A prospective proof-of-concept study
Ann Liebert, Brian Bicknell, E‐Liisa Laakso, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 5
Metabolism and disposition of opicapone in the rat and metabolic enzymes phenotyping
Ana I. Loureiro, Carlos Fernandes‐Lopes, Maria João Bonifácio, et al.
Pharmacology Research & Perspectives (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top